Literature DB >> 1853856

Multivariate analysis of the risk of stomach cancer after ulcer surgery in an Amsterdam cohort of postgastrectomy patients.

A C Tersmette1, S N Goodman, G J Offerhaus, K W Tersmette, F M Giardiello, J P Vandenbroucke, G N Tytgat.   

Abstract

Although gastric cancer incidence is decreasing in the western world, it remains an important cause of death, and there has been debate about screening persons who have undergone gastrectomy for benign ulcers. The authors analyzed risk factors for stomach cancer mortality in an Amsterdam cohort of 2,633 postgastrectomy patients, followed from their initial surgery between 1931 and 1960 until 1975, with 99.7% complete follow-up. Increased stomach cancer mortality was observed in the study population (compared with the general Dutch population) among males 25 years or more after surgery (observed/expected, 5.0; 95% confidence interval (Cl) 2.8-8.3), and among females 15-24 years postoperatively (observed/expected, 3.5; 95% Cl 1.0-9.0). A multivariate Poisson regression analysis showed that after control for age at time of surgery and calendar year of operation, the most important risk factors were time since surgery (0-4 years, relative risk (RR) = 1.0; 5-14 years, RR = 4.1, 95% Cl 0.93-18.5; 15-24 years, RR = 9.4, 95% Cl 2.1-42.3; and 25-46 years, RR = 55.6, 95% Cl 11.7-265.4) and ulcer location (gastric versus duodenal ulcer, RR = 2.6, 95% Cl 1.4-4.8). Surveillance for postgastrectomy cancer could be considered 15-25 years after a patient undergoes surgery for gastric ulcer disease.

Entities:  

Mesh:

Year:  1991        PMID: 1853856     DOI: 10.1093/oxfordjournals.aje.a115988

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  Chromoendoscopic evaluation of gastric mucosa after partial gastrectomy by use of modified endoscopic Congo red test.

Authors:  Ervin Tóth; Kristina Sjölund; Henrik Thorlacius
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

Review 2.  Controversy surrounding 'mini' gastric bypass.

Authors:  Kamal K Mahawar; William R J Carr; Shlok Balupuri; Peter K Small
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

3.  Carcinogenic potential of duodenal reflux juice from patients with long-standing postgastrectomy.

Authors:  Z F Ma; Z Y Wang; J R Zhang; P Gong; H L Chen
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

4.  Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach.

Authors:  I O Baas; B P van Rees; A Musler; M E Craanen; G N Tytgat; F M van den Berg; G J Offerhaus
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

5.  Risk factors for complications during surgical treatment of remnant gastric cancer.

Authors:  In Gyu Kwon; In Cho; Yoon Young Choi; Woo Jin Hyung; Choong Bai Kim; Sung Hoon Noh
Journal:  Gastric Cancer       Date:  2014-04-05       Impact factor: 7.370

6.  Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery.

Authors:  Isao Nozaki; Junichirou Nasu; Yoshiro Kubo; Minoru Tanada; Rieko Nishimura; Akira Kurita
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

7.  Pancreatic cancer after remote peptic ulcer surgery.

Authors:  M Tascilar; B P van Rees; P D J Sturm; G N J Tytgat; R H Hruban; S N Goodman; F M Giardiello; G J A Offerhaus; A C Tersmette
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

8.  Management of gastric remnant carcinoma based on the results of a 15-year endoscopic screening program.

Authors:  F L Greene
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

9.  Gastrectomy and subsequent risk of oesophageal cancer in Milan.

Authors:  C La Vecchia; B D'Avanzo; E Negri; S Franceschi; P Boyle
Journal:  J Epidemiol Community Health       Date:  1994-06       Impact factor: 3.710

10.  Discovery of early gastric remnant carcinoma. Results of a 14-year endoscopic screening program.

Authors:  F L Greene
Journal:  Surg Endosc       Date:  1995-11       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.